
TAMPA – The National Security Commission on Emerging Biotechnology visited Tampa Bay and Gainesville to learn more about the research institutions, health care systems and other resources supporting Florida’s growing biotechnology industry.
The visit was part of the NSCEB’s Biotech Across America Roadshow.
The roadshow visit highlighted opportunities to strengthen regional collaboration, accelerate innovation, develop a skilled biotechnology workforce and advance American leadership in the industry.
“The NSCEB’s visit showcased Florida’s growing life sciences sector, which connects a dedicated, well-educated workforce to cutting-edge cross-disciplinary science in an ecosystem determined to treat and cure the nation’s most difficult diseases,” said NSCEB Executive Director Caitlin Frazer. “The next iteration of biotech innovation is happening in Tampa and Gainesville, and the commission is excited for the region’s role in the biotechnology ecosystem to continue to grow.”
The Tampa Bay tour included visits to Tampa General Hospital’s Care Coordination Center, the University of South Florida’s Center for Advanced Medical Learning and Simulation, USF CONNECT and USF Research Park.
The day culminated at Speros, Moffitt Cancer Center’s 775-acre life sciences campus in Pasco County, where NSCEB staff attended the grand opening of the 250,000-square-foot Moffitt Discovery and Innovation Center.
By the end of 2026, the facility is expected to house about 250 researchers and staff specializing in drug discovery, bioengineering, cancer metabolism and other promising areas of cancer research. It will also support biotechnology incubation and radiopharmaceutical research and development, connecting scientific discovery with opportunities for commercialization and industry partnerships.
While at Speros, NSCEB staff delivered a briefing on the commission’s work. Regional leaders discussed strategies to strengthen the biotech ecosystem and Florida’s long-term competitiveness.
Participants also discussed developing a skilled workforce, commercializing research, supporting startups and building public-private partnerships to advance emerging technologies such as radiopharmaceuticals.
The roadshow continued in Gainesville with a visit to UF Biotility, hosted by UF Innovate at the University of Florida.
“Florida has an extraordinary opportunity to become a national leader in biotechnology,” said Hannah Mae Merten, executive director of strategy for Speros by Moffitt. “Across Tampa Bay, we have world-class research institutions, clinical expertise, entrepreneurial talent and growing infrastructure. By connecting these assets, investing in workforce development and bridging our regional institutions, we can accelerate scientific discovery, attract investment, create high-quality jobs and bring life-changing innovations to patients.”
The NSCEB was established by Congress to examine the national security implications of emerging biotechnology and develop recommendations to strengthen U.S. leadership and competitiveness in the rapidly advancing field.
The visit comes amid significant momentum for Florida’s biotechnology industry.
On Oct. 29, the U.S. Economic Development Administration announced a $47.3 million grant to the FORGE coalition, led by Moffitt Cancer Center and Speros in partnership with the University of South Florida, Pasco-Hernando State College and Embarc Collective.
The investment will help establish Tampa Bay as a Southeastern hub for radiopharmaceutical innovation and manufacturing, strengthening the region’s role in advancing next-generation cancer treatments and biotechnology innovation.